Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms

Journal of Autism and Developmental Disorders

Volumn 47, Issue 11, 2017, Pages 3358-3369

  Sheppard, Kelly W ^a,d   Boone, Kelly M ^a   Gracious, Barbara ^a,d   Klebanoff, Mark A ^a,d   Rogers, Lynette K ^a,d   Rausch, Joseph ^a   Bartlett, Christopher ^b,d   Coury, Daniel L ^a,c   Keim, Sarah A ^a,d  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Autism spectrum disorder; Children born preterm; Language development; MacArthur Bates communicative development inventory; Omega 3 fatty acids; Omega 6 fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO;

ARTICLE; AUTISM; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FAMILY INCOME; FEASIBILITY STUDY; FEMALE; HUMAN; LANGUAGE ABILITY; LANGUAGE DEVELOPMENT; MALE; PILOT STUDY; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; THERAPY EFFECT; TODDLER; CHILD; DIETARY SUPPLEMENT; GROWTH, DEVELOPMENT AND AGING; INFANT; NEWBORN; PRESCHOOL CHILD;

AUTISM SPECTRUM DISORDER; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; LANGUAGE DEVELOPMENT; MALE;

EID: 85026894114     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-017-3249-3     Document Type: Article

References (94)

1. Ahmad, A., Moriguchi, T., & Salem, N. (2002a). Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatric Neurology, 26, 210–218.
2. Ahmad, A., Murthy, M., Moriguchi, T., Salem, N., & Greiner, R. S. (2002b). A decrease in cell size accompanies a loss of docosahexaenoate in the rat hippocampus. Nutritional Neuroscience, 5, 103–113. doi:10.1080/10284150290018973.
3. Aid, S., Vancassel, S., Poumes-Ballihaut, C., Chalon, S., Guesnet, P., & Lavialle, M. (2003). Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. Journal of Lipid Research, 44, 1545–1551. doi:10.1194/jlr.M300079-JLR200.
4. Pan, B.A., Rowe, M. L., Spier, E., & Tamis-Lemonda, C. (2004). Measuring productive vocabulary of toddlers in low-income families: Concurrent and predictive validity of three sources of data. Journal of Child Language, 31, 587–608. doi:10.1017/s0305000904006270.
5. Amminger, G. P., Berger, G. E., Schafer, M. R., Klier, C., Friedrich, M. H., & Feucht, M. (2007). Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study. Biological Psychiatry, 61, 551–553. doi:10.1016/j.biopsych.2006.05.007.
6. Arriaga, R. I., Fenson, L., Cronan, T., Pethick, S. J. (2008). Scores on the MacArthur Communicative Development Inventory of children from lowand middle-income families. Applied Psycholinguistics, 19, 209 doi:10.1017/s0142716400010043.
7. Auestad, N., et al. (2001). Growth and development in term infants fed long-chain polyunsaturated fatty acids: A double-masked, randomized, parallel, prospective, multivariate study. Pediatrics, 108, 372–381. doi:10.1542/peds.108.2.372.
8. Barden, A. E., Mas, E., & Mori, T. A. (2016). n-3 Fatty acid supplementation and proresolving mediators of inflammation. Current Opinion in Lipidology, 27, 26–32. doi:10.1097/MOL.0000000000000262.
9. Bent, S., et al. (2014). Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 53, 658–666. doi:10.1016/j.jaac.2014.01.018.
10. Bliss, T.V.P., & Collingridge, G. L. (1993). A synaptic model of memory: Long-term potentiation in the hippocampus. Nature, 361, 31–39.
11. Bourre, J. M., et al. (1989). The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. Journal of Nutrition, 119, 1880–1892.
12. Bourre, J.M., et al. (1993). Function of dietary polyunsaturated fatty acids in nervous system. Prostaglandins, Leukotrienes and Essential Fatty Acids, 48, 5–15.
13. Bowen, K. J., Harris, W. S., & Kris-Etherton, P. M. (2016). Omega-3 fatty acids and cardiovascular disease: Are there benefits? Current Treatment Options in Cardiovascular Medicine, 18, 69. doi:10.1007/s11936-016-0487-1.
14. Breckenridge, W. C., Morgan, I. G., Zanetta, J. P., & Vincendon, G. (1973). Adult rat brain synaptic vesicles II. Lipid composition. Biochimica et Biophysica Acta, 320, 681–686.
15. Bruckner, C., Yoder, P., Stone, W., & Saylor, M. (2007). Construct validity of the MCDI-I receptive vocabulary scale can be improved: Differential item functioning between toddlers with autism spectrum disorders and typically-developing infants. Journal of Speech Language and Hearing Research, 50, 1631–1638.
16. Catalan, J., Moriguchi, T., Slotnick, B., Murthy, M., Greiner, R. S., & Salem, N. (2002). Cognitive deficits in docosahexaenoic acid-deficient rats. Behavioral Neuroscience, 116, 1022–1031. doi:10.1037/0735-7044.116.6.1022.
17. Cattani, A., Bonifacio, S., Fertz, M., Iverson, J. M., Zocconi, E., & Caselli, M. C. (2010). Communicative and linguistic development in preterm children: a longitudinal study from 12 to 24 months. International Journal of Language & Communication Disorders, 45, 162–173. doi:10.3109/13682820902818870.
18. Chalon, S., et al. (1998). Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. Journal of Nutrition, 128, 2512–2519.
19. Clandinin, M. T., et al. (2005). Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. The Journal of pediatrics, 146, 461–468. doi:10.1016/j.jpeds.2004.11.030.
20. Clandinin, M. T., Cheema, S., Field, J., Garg, M. L., Venkatraman, J., & Clandinin, T. R. (1991). Dietary fat: Exogenous determination of membrane structure and cell function. FASEB Journal, 5, 2761–2769.
21. Coderre, E. L., Chernenok, M., Gordon, B., & Ledoux, K. (2017). Linguistic and non-linguistic semantic processing in individuals with autism spectrum disorders: An ERP study. Journal of Autism and Developmental Disorders. doi:10.1007/s10803-016-2985-0.
22. Dale, P. S. (1991). The validity of a parent report measure of vocabulary and syntax at 24 months. Journal of Speech and Hearing Research, 34, 565–571.
23. Delion, S., Chalon, S., Herault, J., Guilloteau, D., Besnard, J.-C., & Durand, G. (1994). Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. Journal of Nutrition, 124, 2466–2476.
24. du Bois, T. M., Deng, C., Bell, W., & Huang, X. F. (2006). Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience, 139, 1397–1403. doi:10.1016/j.neuroscience.2006.02.068.
25. Dyall, S. C., & Michael-Titus, A. T. (2008). Neurological benefits of omega-3 fatty acids. Neuromolecular Medicine, 10, 219–235. doi:10.1007/s12017-008-8036-z.
26. Fang, Y. J., Zhou, M. H., Gao, X. F., Gu, H., & Mei, Y. A. (2011). Arachidonic acid modulates Na+ currents by non-metabolic and metabolic pathways in rat cerebellar granule cells. The Biochemical Journal, 438, 203–215. doi:10.1042/BJ20110569.
27. Farvid, M. S., et al. (2014). Dietary linoleic acid and risk of coronary heart disease: A systematic review and meta-analysis of prospective cohort studies. Circulation, 130, 1568–1578. doi:10.1161/CIRCULATIONAHA.114.010236.
28. Fenson, L., Pethick, S. J., Renda, C., Cox, J. L. (2000). Short-form versions of the MacArthur communicative development inventories. Applied Psycholinguistics, 21, 95–116.
29. Fewtrell, M. S., et al. (2004). Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. The Journal of Pediatrics, 144, 471–479. doi:10.1016/j.jpeds.2004.01.034.
30. Foster-Cohen, S., Edgin, J. O., Champion, P. R., & Woodward, L. J. (2007). Early delayed language development in very preterm infants: Evidence from the MacArthur-Bates CDI. Journal of Child Language, 34, 655. doi:10.1017/s0305000907008070.
31. Frank, M. C., Braginsky, M., Yurovsky, D., Marchman, V.A. (2016). Wordbank: An open repository for developmental vocabulary data. Journal of Child Language, 1–18. doi:10.1017/S0305000916000209.
32. Garton, A. F. (1985). The production of this and that by young children. First Language, 6, 29–39.
33. Gibson, R. A., Neumann, M. A., Lien, E. L., Boyd, K. A., & Tu, W. C. (2013). Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. Prostaglandins Leukotrienes and Essential Fatty Acids, 88, 139–146. doi:10.1016/j.plefa.2012.04.003.
34. Gordon, R. G., & Watson, L. R. (2015). Brief report: Gestures in children at risk for autism spectrum disorders. Journal of Autism and Developmental Disorders, 45, 2267–2273. doi:10.1007/s10803-015-2390-0.
35. Groen, W. B., Zwiers, M. P., van der Gaag, R. J., & Buitelaar, J. K. (2008). The phenotype and neural correlates of language in autism: An integrative review. Neuroscience and Biobehavioral Reviews, 32, 1416–1425. doi:10.1016/j.neubiorev.2008.05.008.
36. Harnack, K., Andersen, G., & Somoza, V. (2009). Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids. Nutrition Metabolism, 6, 8. doi:10.1186/1743-7075-6-8.
37. Harris, W. S. (2006). The omega-6/omega-3 ratio and cardiovascular disease risk: Uses and abuses. Current Atherosclerosis Reports, 8, 453–459.
38. Henriksen, C., et al. (2008). Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics, 121, 1137–1145. doi:10.1542/peds.2007-1511.
39. Ikemoto, A., Kobayashi, T., Watanabe, S., & Okuyama, H. (1997). Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release. Neurochemical Research, 22, 671–678.
40. Innis, S. M. (2014). Omega-3 fatty acid biochemistry: Perspectives from human nutrition. Military Medicine, 179, 82–87. doi:10.7205/MILMED-D-14-00147.
41. Johnson, M., Fransson, G., Ostlund, S., Areskoug, B., & Gillberg, C. (2016). Omega 3/6 fatty acids for reading in children: A randomized, double-blind, placebo-controlled trial in 9-year-old mainstream schoolchildren in Sweden. Journal of Child Psychology and Psychiatry and Allied Disciplines. doi:10.1111/jcpp.12614.
42. Johnson, S., Hollis, C., Kochhar, P., Hennessey, E., Wolke, D., & Marlow, N. (2010). Autism spectrum disorders in extremely preterm children. Journal of Pediatrics, 156, 525–531.
43. Jucaite, A., Fernell, E., Halldin, C., Forssberg, H., & Farde, L. (2005). Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity. Biological Psychiatry, 57, 229–238. doi:10.1016/j.biopsych.2004.11.009.
44. Jumpsen, J., Lien, E. L., Goh, Y. K., & Clandinin, M. T. (1997a). During neuronal and glial cell development diet n-6 to n-3 fatty acid ratio alters the fatty acid composition of phosphatidylinositol and phosphatidylserine. Biochimica et Biophysica Acta, 1347, 40–50.
45. Jumpsen, J., Lien, E. L., Goh, Y. K., & Clandinin, M. T. (1997b). Small changes of dietary (n-6) and (n-3)/fatty acid content ratio alter phosphatidylethanolamine and phosphatidylcholine fatty acid composition during development of neuronal and glial cells in rats. Journal of Nutrition, 127, 724–731.
46. Kato, K., Uruno, K., Saito, K., & Kato, H. (1991). Both arachidonic acid and 1-oleoyl-2-acetyl glycerol in low magnesium solution induce long-term potentiation in hippocampal CA1 neurons in vitro. Brain Research, 563, 94–100.
47. Keim, S. A., et al. (under review). Omega-3 and -6 fatty acid supplementation may benefit autism symptoms based on parent report in preterm toddlers. The Journal of Nutrition.
48. Koletzko, B., et al. (2008). The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: Review of current knowledge and consensus recommendations. Journal of Perinatal Medicine, 36, 5–14. doi:10.1515/JPM.2008.001.
49. Kris-Etherton, P., Fleming, J., & Harris, W. S. (2010). The debate about n-6 polyunsaturated fatty acid recommendations for cardiovascular health. Journal of the American Dietetic Association, 110, 201–204. doi:10.1016/j.jada.2009.12.006.
50. Kuzniewicz, M. W., Wi, S., Qian, Y., Walsh, E. M., Armstrong, M. A., & Croen, L. A. (2014). Prevalence and neonatal factors associated with autism spectrum disorders in preterm infants. The Journal of Pediatrics, 164, 20–25. doi:10.1016/j.jpeds.2013.09.021.
51. Lapillonne, A., & Moltu, S. J. (2016). Long-chain polyunsaturated fatty acids and clinical outcomes of preterm infants. Annals of Nutrition and Metabolism, 69(Suppl 1), 35–44. doi:10.1159/000448265.
52. Lauritzen, L., Jorgensen, M. H., Olsen, S. F., Straarup, E. M., & Michaelsen, K. F. (2005). Maternal fish oil supplementation in lactation: Effect on developmental outcome in breast-fed infants. Reproduction Nutrition Development, 45, 535–547. doi:10.1051/rnd:2005044.
53. LeBarton, E. S., Goldin-Meadow, S., & Raudenbush, S. (2015). Experimentally-induced Increases in Early gesture lead to increases in spoken vocabulary. Journal of Cognition and Development, 16, 199–220. doi:10.1080/15248372.2013.858041.
54. LeBarton, E. S., & Iverson, J. M. (2016). Gesture development in toddlers with an older sibling with autism. International Journal of Language & Communication Disorders, 51, 18–30. doi:10.1111/1460-6984.12180.
55. Lee, J.M., Lee, H., Kang, S., Park, W. J. (2016). Fatty acid desaturases, polyunsaturated fatty acid regulation, and biotechnological advances. Nutrients, 8, 23. doi:10.3390/nu8010023.
56. Lynch, M. A., & Voss, K. L. (1994). Membrane arachidonic acid concentration correlates with age and induction of long-term potentiation in the dentate gyrus in the rat. European Journal of Neuroscience, 6, 1008–1014.
57. Mankad, D., et al. (2015). A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism. Molecular Autism, 6, 18. doi:10.1186/s13229-015-0010-7.
58. Martinez, M. (1992). Tissue levels of polyunsaturated fatty acids during early human development. Journal of Pediatrics, 120, S129–S138.
59. Martinez, M., & Mougan, I. (1998). Fatty acid composition of human brain phospholipids during normal development. Journal of Neurochemistry, 71, 2528–2533.
60. McNamara, R. K., et al. (2007). Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biological Psychiatry, 62, 17–24. doi:10.1016/j.biopsych.2006.08.026.
61. McNamara, R. K. (2010). DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders. The Journal of Nutrition, 140, 864–868. doi:10.3945/jn.109.113233.
62. McNamara, R. K., Jandacek, R., Rider, T., Tso, P., Dwivedi, Y., & Pandey, G. N. (2010). Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. Journal of Affective Disorders, 126, 303–311. doi:10.1016/j.jad.2010.03.015.
63. McNamara, R. K., & Liu, Y. (2011). Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder. Journal of Affective Disorders, 129, 359–363. doi:10.1016/j.jad.2010.08.021.
64. Meldrum, S. J., D’Vaz, N., Simmer, K., Dunstan, J. A., Hird, K., & Prescott, S. L. (2012). Effects of high-dose fish oil supplementation during early infancy on neurodevelopment and language: A randomised controlled trial. The British Journal of Nutrition, 108, 1443–1454. doi:10.1017/S0007114511006878.
65. Mody, M., et al. (2017). Communication deficits and the motor system: exploring patterns of associations in autism spectrum disorder (ASD). Journal of Autism and Developmental Disorders, 47, 155–162. doi:10.1007/s10803-016-2934-y.
66. Moriguchi, T., Greiner, R. S., & Salem, N. (2000). Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. Journal of Neurochemistry, 75, 2563–2573.
67. Mundy, P., Sigman, M., Ungerer, J., & Sherman, T. (1987). Nonverbal communnication and play correlates of language development in autistic children. Journal of Autism and Developmental Disorders, 17, 349–364.
68. Nakamura, M. T., & Nara, T. Y. (2004). Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annual Review of Nutrition, 24, 345–376. doi:10.1146/annurev.nutr.24.121803.063211.
69. Ozcaliskan, S., Adamson, L. B., & Dimitrova, N. (2016). Early deictic but not other gestures predict later vocabulary in both typical development and autism. Autism, 20, 754–763. doi:10.1177/1362361315605921.
70. Parlade, M. V., & Iverson, J. M. (2015). The development of coordinated communication in infants at heightened risk for autism spectrum disorder. Journal of Autism and Developmental Disorders, 45, 2218–2234. doi:10.1007/s10803-015-2391-z.
71. Parletta, N., Niyonsenga, T., Duff, J. (2016). Omega-3 and omega-6 polyunsaturated fatty acid levels and correlations with symptoms in children with attention deficit hyperactivity disorder, autistic spectrum disorder and typically developing controls. PLoS ONE. doi:10.4226/78/572fdf0edfb74.
72. Patrick, R. P., & Ames, B. N. (2015). Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: Relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. The FASEB Journal, 29, 2207–2222. doi:10.1096/fj.14-268342.
73. Pritchard, M. A., et al. (2016). Autism in toddlers born very preterm. Pediatrics, 137, e20151949. doi:10.1542/peds.2015-1949.
74. Rescorla, L. (1991). Identifying expressive language delay at two. Topics in Language Disorders, 11, 14–20.
75. Richardson, A. J., & Montgomery, P. (2005). The Oxford-Durham study: A randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics, 115, 1360–1366. doi:10.1542/peds.2004-2164.
76. Ring, E.D., Fenson, L. (2000). The correspondence between parent report and child performance for receptive and expressive vocabulary beyond infancy. First Language, 20, 141–159.
77. Sansavini, A., et al. (2011). Longitudinal trajectories of gestural and linguistic abilities in very preterm infants in the second year of life. Neuropsychologia, 49, 3677–3688. doi:10.1016/j.neuropsychologia.2011.09.023.
78. Schaechter, J. D., & Benowitz, L. I. (1993). Activation of protein kinase C by arachidonic acid selectively enhances the phosphorylation of GAP-43 in nerve terminal membranes. The Journal of Neuroscience, 13, 4361–4371.
79. Schneider, M. R., DelBello, M. P., McNamara, R. K., Strakowski, S. M., & Adler, C. M. (2012). Neuroprogression in bipolar disorder. Bipolar Disorders, 14, 356–374. doi:10.1111/j.1399-5618.2012.01024.x.
80. Scott, D. T., Janowsky, J. S., Carroll, R. E., Taylor, J. A., Auestad, N., & Montalto, M. B. (1998). Formula supplementation with long-chain polyunsaturated fatty acids: Are there developmental benefits? Pediatrics, 102, e59–e59. doi:10.1542/peds.102.5.e59.
81. Serhan, C. N., & Savill, J. (2005). Resolution of inflammation: The beginning programs the end. Nature Immunology, 6, 1191–1197. doi:10.1038/ni1276.
82. Sheppard, K. W., & Cheatham, C. L. (2017). Executive functions and the omega-6-to-omega-3 fatty acid ratio: A cross-sectional study. The American Journal of Clinical Nutrition, 105, 32–41. doi:10.3945/ajcn.116.141390.
83. Simmer, K., Schulzke, S., Patole, S. K. (2008). Longchain polyunsaturated fatty acid supplementation in preterm infants (Review). The Cochrane Library, 1, 1–57.
84. Spencer, T. J., et al. (2007). Further evidence of dopamine transporter dysregulation in ADHD: A controlled PET imaging study using altropane. Biological Psychiatry, 62, 1059–1061. doi:10.1016/j.biopsych.2006.12.008.
85. Spittle, A. J., et al. (2017). Neurobehaviour at term-equivalent age and neurodevelopmental outcomes at 2 years in infants born moderate-to-late preterm. Developmental Medicine and Child Neurology, 59, 207–215. doi:10.1111/dmcn.13297.
86. Verhaeghe, L., Dereu, M., Warreyn, P., De Groote, I., Vanhaesebrouck, P., & Roeyers, H. (2016). Extremely preterm born children at very high risk for developing autism spectrum disorder. Child Psychiatry and Human Development, 47, 729–739. doi:10.1007/s10578-015-0606-3.
87. Voigt, R. G., et al. (2014). Dietary docosahexaenoic acid supplementation in children with autism. Journal of Pediatric Gastroenterology and Nutrition, 58, 715–722. doi:10.1097/MPG.0000000000000260.
88. Wainwright, P. E., Jalali, E., Mutsaers, M., Bell, R., & Cvitkovic, S. (1999). An imbalance of dietary essential fatty acids retards behavioral development in mice. Physiology and Behavior, 66, 833–839.
89. Wainwright, P. E., Xing, H.-C., Mutsaers, L., McCutcheon, D., & Kyle, D. (1997). Arachidonic acid offsests the effects of mouse brain and behavior of a diet with low (n−6):(n−3) ratio and very high levels of docosahexaenoic acid. Journal of Nutrition, 127, 184–193.
90. Weiser, M. J., Wynalda, K., Salem, N. Jr., Butt, C. M. (2015). Dietary DHA during development affects depression-like behaviors and biomarkers that emerge after puberty in adolescent rats. Journal of Lipid Research, 56, 151–166. doi:10.1194/jlr.M055558.
91. Willatts, P., Forsyth, J. S. (2000). The role of long-chain polyunsaturated fatty acids in infant cognitive development. Prostaglandins Leukotrienes and Essential Fatty Acids, 63, 95–100.
92. Willett, W., et al. (1985). Reproducibility and validity of a semiquantitative food frequency questionnaire. American Journal of Epidemiology, 122, 51–65.
93. Winkens, B., van Breukelen, G. J., Schouten, H. J., & Berger, M. P. (2007). Randomized clinical trials with a pre- and a post-treatment measurement: Repeated measures versus ANCOVA models. Contemporary Clinical Trials, 28, 713–719. doi:10.1016/j.cct.2007.04.002.
94. Zimmer, L., Delpal, S., Guilloteau, D., Aioun, J., Durand, G., & Chalon, S. (2000). Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neuroscience Letters, 284, 25–28.